Viggo I. Van Tendeloo

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA.

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA.

Journal: Experimental hematology & oncology

Published: December 18, 2025

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.

Journal: Pharmaceutics

Published: January 19, 2021

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.

Journal: Frontiers in immunology

Published: February 03, 2019

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

Journal: Oncotarget

Published: January 16, 2018

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

Journal: Frontiers in immunology

Published: January 15, 2018

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion.

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion.

Journal: Cancer immunology research

Published: November 22, 2016

The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells.

The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells.

Journal: Oncotarget

Published: January 26, 2016

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

Journal: Cancer immunology, immunotherapy : CII

Published: November 04, 2014

Interleukin-15: new kid on the block for antitumor combination therapy.

Interleukin-15: new kid on the block for antitumor combination therapy.

Journal: Cytokine & growth factor reviews

Published: August 28, 2014

Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.

Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.

Journal: Transplantation

Published: July 23, 2014

Loading of acute myeloid leukemia cells with poly(I:C) by electroporation.

Loading of acute myeloid leukemia cells with poly(I:C) by electroporation.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 13, 2014

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.

Journal: Journal of cellular and molecular medicine

Published: November 11, 2013

Showing 1-12 of 18

Last Updated: 09/26/2026